PSI (TFA) is a potent proteasome inhibitor. PSI (TFA) inhibits the proliferation of primary effusion lymphoma (PEL) cells. PSI (TFA) can be used for the research of Kaposis sarcoma-associated herpesvirus (KSHV) infection and KSHV-associated lymphomas[1].
Molecular Weight:
732.78
Formula:
C34H51F3N4O10
Target:
Proteasome
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
